Center for Redox Biology and Cardiovascular Disease
Funded at Louisiana State Univ Hsc Shreveport · NIH-11379097 · Data updated 2026-11-12
A large, long-running program at LSU Health Shreveport is exploring how redox biology affects heart and blood vessel diseases to improve prevention and treatment for patients in Louisiana and beyond.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Louisiana State Univ Hsc Shreveport NIH-funded |
| Lab location | 1 site (Shreveport, United States) |
| Project start | February 1, 2018 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $2,162,425 |
| NIH project number | 5P20GM121307-09 |
| Project ID | NIH-11379097 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with cardiovascular disease or at risk due to redox-related mechanisms in Louisiana and surrounding regions.
✕Less likely to help
Patients without cardiovascular disease or with conditions not linked to redox biology may not directly benefit.
What this research studies
This program studies how oxidative stress and antioxidant defenses influence cardiovascular disease. It combines multiple junior investigators to advance redox biology research and intends to recruit and develop new faculty to strengthen the research team. The work uses state-of-the-art methods to uncover disease mechanisms that could lead to better therapies and interventions for heart disease. It aims to build a strong, translational research environment that could ultimately benefit patients with cardiovascular conditions.
Why it matters
Potential benefit: If successful, the program could uncover new targets and strategies to prevent or treat cardiovascular disease in patients.
How similar studies have gone: Previous redox biology work has identified links between oxidative stress and heart disease, but ongoing work seeks to define specific pathways and therapeutic angles.
Where this research is happening
-
Louisiana State Univ Hsc Shreveport
Shreveport, United States Active
Researchers
- Principal investigator: Kevil, Christopher G — Louisiana State Univ Hsc Shreveport
- Study coordinator: Kevil, Christopher G
Related research
Other NIH-funded projects on the same topics.
-
Understanding how genetic changes in blood cells relate to heart disease in people with HIV
A study will look at how age-related blood cell mutations and large chromosomal changes might contribute to heart disease risk in people living with HIV.
-
Food allergy antibodies linked to heart disease risk in adults
Many adults have antibodies to foods without symptoms, and this study asks whether those antibodies are linked to higher risk of heart disease and related conditions.
-
Mindfulness training to lower cardiovascular risk for moms and babies during pregnancy
A mindfulness program is being tested during pregnancy to help prevent high blood pressure and heart problems for mothers and their babies.
-
Integrating clinical pharmacists into HIV care to reduce cardiovascular disease in people with HIV
A pharmacist-led program in HIV care aims to prevent and manage heart disease risks like high blood pressure, diabetes, and high cholesterol in people living with HIV.
-
Integrating heart care into HIV services in Botswana using statins
This project tests a simple, scalable approach to help people with HIV in Botswana start and stay on statin therapy to prevent heart attacks and strokes.
-
A heart-healthy program for aging HIV patients using therapy pets to help blood pressure
A study tests whether using the human-animal bond from dog ownership can help older adults living with HIV control their blood pressure and improve heart health.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.